THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018 ...
PITTSBURGH, PA / ACCESS Newswire / April 14, 2026 / The World Tumor Registry ("WTR"), a global non-profit organization with a mission to improve cancer patient outcomes through better diagnosis and ...
Silicon Valley-based firm targets $100 million and aims to connect U.S. early-stage innovation with Japanese enterprises.SAN ...
Expands UL Solutions’ global laboratory footprint and enhances commitment to TIC services for electrical safety and connected productsTransaction expected to close in Q4 2026 subject to regulatory ...
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announces ...
NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease ...
CHICAGO, IL / ACCESS Newswire / April 13, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that ...
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and ...
Lung01 Phase 2 trial, with support from IDeate-PanTumor01 Phase 1/2 trialIf approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients ...
Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with ...
Board-certified plastic surgeon expands his practice to serve patients in Princeton, NJ and Philadelphia, PA. PRINCETON, NJ AND PHILADELPHIA, PA / ACCESS Newswire / April 13, 2026 / Dr. David W.
Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results